New strategies in anti-thrombotic therapy offer efficacy, cost savings.
New studies are showing that treating patients on an outpatient basis with injectable heparin is just as safe and effective--as well as less costly--as the traditional inpatient approach.
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004502:Education, Medical, Continuing; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D020407:Internet; D010359:Patient Readmission; D016896:Treatment Outcome; D014481:United States; D020246:Venous Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight